ANI Pharmaceuticals, Inc. (ANIP)
81.34
-0.43
(-0.53%)
USD |
NASDAQ |
Dec 08, 16:00
82.45
+1.11
(+1.36%)
Pre-Market: 09:22
ANI Pharmaceuticals Shareholders Equity (Quarterly): 505.82M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CorMedix, Inc. | 374.13M |
| Arcutis Biotherapeutics, Inc. | 158.07M |
| Intellia Therapeutics, Inc. | 748.42M |
| Beam Therapeutics, Inc. | 966.00M |
| Halozyme Therapeutics, Inc. | 503.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.408B |
| Total Liabilities (Quarterly) | 902.34M |
| Debt to Equity Ratio | 1.249 |
| Current Ratio | 2.581 |
| Net Debt Paydown Yield | -3.12% |